A pilot trial of Saccharomyces boulardii in ulcerative colitis.
作者： Mario Guslandi , Patrizia Giollo , Pier Alberto Testoni
DOI: 10.1097/00042737-200306000-00017
关键词:
摘要: ObjectivesProbiotics can be useful in the treatment of inflammatory bowel disease. In a previous report, non-pathogenic yeast Saccharomyces boulardii was found to beneficial maintenance Crohn's The aim this study assess efficacy S. ul
optibacprobiotics.co.uk
elsevier.com
lww.com 参考文章(13)
G. Bleichner, H. Bléhaut, H. Mentec, D. Moyse, Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Medicine. ,vol. 23, pp. 517- 523 ,(1997) , 10.1007/S001340050367
Michael B. Kimmey, Gary W. Elmer, Christina M. Surawicz, Lynne V. McFarland, Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii Digestive Diseases and Sciences. ,vol. 35, pp. 897- 901 ,(1990) , 10.1007/BF01536805
W. KRUIS, E. SCHUTZ, P. FRIC, B. FIXA, G. JUDMAIER, M. STOLTE, Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Alimentary Pharmacology & Therapeutics. ,vol. 11, pp. 853- 858 ,(1997) , 10.1046/J.1365-2036.1997.00225.X
Balfour Sartor, The role of luminal bacteria in colitis: more than an antigenic drive European Journal of Clinical Investigation. ,vol. 28, pp. 1027- 1029 ,(1998) , 10.1046/J.1365-2362.1998.00404.X
BJ Rembacken, AM Snelling, PM Hawkey, DM Chalmers, ATR Axon, Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. The Lancet. ,vol. 354, pp. 635- 639 ,(1999) , 10.1016/S0140-6736(98)06343-0
Fergus Shanahan, Probiotics and inflammatory bowel disease: Is there a scientific rationale? Inflammatory Bowel Diseases. ,vol. 6, pp. 107- 115 ,(2000) , 10.1097/00054725-200005000-00007
Mario Guslandi, Probiotics for chronic intestinal disorders. The American Journal of Gastroenterology. ,vol. 98, pp. 520- 521 ,(2003) , 10.1111/J.1572-0241.2003.07307.X
Paolo Gionchetti, Fernando Rizzello, Alessandro Venturi, Patrizia Brigidi, Diego Matteuzzi, Gabriele Bazzocchi, Gilberto Poggioli, Mario Miglioli, Massimo Campieri, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial Gastroenterology. ,vol. 119, pp. 305- 309 ,(2000) , 10.1053/GAST.2000.9370
Mario Guslandi, Gianni Mezzi, Massimo Sorghi, Pier Alberto Testoni, Saccharomyces boulardii in maintenance treatment of Crohn's disease. Digestive Diseases and Sciences. ,vol. 45, pp. 1462- 1464 ,(2000) , 10.1023/A:1005588911207
U TURUNEN, M FARKKILA, K HAKALA, K SEPPALA, A SIVONEN, M OGREN, M VUORISTO, V VALTONEN, T MIETTINEN, Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study Gastroenterology. ,vol. 115, pp. 1072- 1078 ,(1998) , 10.1016/S0016-5085(98)70076-9